Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Braz J Biol ; 84: e268981, 2023.
Article in English | MEDLINE | ID: mdl-36921192

ABSTRACT

In order to investigate the stability of qualitative and quantitative traits and choose the most appropriate cultivation method and irrigation regime in rice plants, the experiment was conducted in the form of a split-plot design based on a randomized complete block design in three replications and in two cropping years. The results of compound analysis indicated that the effect of year × irrigation regimes in terms of traits, grain yield, rainfall, productivity 2, number of full grains, number of hollow grains, harvest index, percentage of crushed grains and yield of white rice, the effect of year × Cultivation method characteristics in terms of water consumption, rainfall, productivity 1, number of tillers, plant height, spike length, number of hollow grains, thousand seed weight, small grain percentage and white rice yield and the effect of irrigation regime × cultivation methods in terms of all Traits except traits productivity 2 were significant. The results of the mean comparison of the interaction effect of irrigation regimes and cultivation methods also showed that treatments T1W1, T2W1 and T1W3 are favorable for all evaluated traits. Based on the table of correlation coefficients, correlation diagram and map of the intensity of the correlation in the years of the experiment, it is possible to report the correlation of the grain yield trait with the traits of water consumption, rainfall, plant height, 100- seed weight, full grain number and white rice yield. Also, traits productivity 1, productivity 2 and small grain percentage showed a positive correlation and a negative correlation of these three traits with most of the traits evaluated in the experiment was observed. Based on the analysis of the main components, the first four main components explained the most data variance, and T2W2 and T2W3 treatments were identified as suitable treatments for rice cultivation in terms of the first and second main components.


Subject(s)
Crop Production , Oryza , Edible Grain , Phenotype , Seeds
2.
Braz J Biol ; 84: e266261, 2022.
Article in English | MEDLINE | ID: mdl-36287530

ABSTRACT

A split-plot experiment was conducted in a randomized complete block design with three replications in two cropping years at Mazandaran Rice Research Institute to study cultivation and irrigation regimes. The main factor is three-level irrigation regimes, permanent irrigation throughout the day (T1), irrigation two days after water disappears from the soil (T2) and permanent soil saturation (T3) the second factor is three-level cultivation methods., Plowless cultivation (W1), stack 60 cm (W2), and stack 80 cm (W3). Based on the results obtained from the combined analysis, the effect of the year was significant in terms of rainfall, productivity 2, number of tillers, number of empty grains, 1000-grain weight, percentage of the crushed grain, and white rice yield. The effect of the main factor was significant for all traits except productivity 1 and plant height. Based on the results of comparing the mean effect of year × treatment, four treatments, without plowing with permanent irrigation throughout the day in the first and second year of the experiment, cultivation without plowing with irrigation two days after water disappears from the soil in the second year of experiment and cultivation without Plowing with permanent saturated irrigation in the first and second years of the experiment was identified in terms of grain yield as suitable planting methods with appropriate irrigation regimes. Based on the results obtained from the polygon view in different years of the experiment, T3W1, T3W2, and T1W1 treatments can be suggested as desirable treatments in terms of irrigation regimes and cultivation methods in this rice cultivar. According to the ranking diagram of treatments based on traits in the years of experimentation, T1W1, T2W2 and T1W3 were introduced as the most desirable treatments for cultivating this rice cultivar.


Subject(s)
Agricultural Irrigation , Oryza , Agricultural Irrigation/methods , Edible Grain/chemistry , Seedlings , Soil , Triticum , Water
3.
Sensors (Basel) ; 20(7)2020 Apr 03.
Article in English | MEDLINE | ID: mdl-32260081

ABSTRACT

Microelectromechanical system (MEMS)-based mass sensors are proposed as potential candidates for highly sensitive chemical and gas detection applications owing to their miniaturized structure, low power consumption, and ease of integration with readout circuits. This paper presents a new approach in developing micromachined mass sensors based on capacitive and piezoelectric transducer configurations for use in low concentration level gas detection in a complex environment. These micromachined sensors operate based on a shift in their center resonant frequencies. This shift is caused by a change in the sensor's effective mass when exposed to the target gas molecules, which is then correlated to the gas concentration level. In this work, capacitive and piezoelectric-based micromachined sensors are investigated and their principle of operation, device structures and configurations, critical design parameters and their candidate fabrication techniques are discussed in detail.

4.
Clin Pharmacol Ther ; 101(6): 721-724, 2017 Jun.
Article in English | MEDLINE | ID: mdl-27859027

ABSTRACT

New therapeutic strategies are urgently needed to improve clinical outcomes in patients with multiple myeloma (MM). Daratumumab is a first-in-class, CD38 human immunoglobulin G1κ monoclonal antibody approved for treatment of relapsed or refractory MM. Identification of an appropriate dose regimen for daratumumab is challenging due to its target-mediated drug disposition, leading to time- and concentration-dependent pharmacokinetics. We describe a thorough evaluation of the recommended dose regimen for daratumumab in patients with relapsed or refractory MM.


Subject(s)
Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/pharmacokinetics , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/pharmacokinetics , Drug Dosage Calculations , Multiple Myeloma/drug therapy , Antibodies, Monoclonal/adverse effects , Antibodies, Monoclonal/blood , Antineoplastic Agents/adverse effects , Antineoplastic Agents/blood , Drug Administration Schedule , Drug Resistance, Neoplasm , Humans , Models, Biological , Multiple Myeloma/blood , Multiple Myeloma/diagnosis , Recurrence , Treatment Outcome
5.
Mater Sci Eng C Mater Biol Appl ; 68: 136-142, 2016 Nov 01.
Article in English | MEDLINE | ID: mdl-27524005

ABSTRACT

The aim of this work was preparation, characterization, bioactivity and biocompatibility evaluation of Mg-substituted fluorapatite (Mg-FA) nanopowders. Mg-FA nanopowders with a chemical composition of Ca10-xMgx(PO4)6F2, with x=0, 0.5, 1, and 2 were prepared by mechanically activated method. The in vitro bioactivity was investigated by soaking the powders in simulated body fluid (SBF) for various time periods to analyze the nucleation and growth of bone-like apatite on the surface of the samples. Cell viability and cell attachment were studied by MTT assay. Results indicated that the bioactivity of all of samples with different Mg content was improved compared with the pure FA. However, the mechanism of bioactivity is different and depends on the amount of Mg substitution. Finally, cell culture suggested that the addition of Mg(2+) has no adverse effect and Mg-FA samples have good biocompatibility. The Mg-FA material shows potential in satisfying the requirements of biomedical applications.


Subject(s)
Apatites , Magnesium , Materials Testing , Nanoparticles/chemistry , Apatites/chemistry , Apatites/pharmacokinetics , Apatites/pharmacology , Body Fluids/chemistry , Cell Line, Tumor , Cell Survival/drug effects , Humans , Magnesium/chemistry , Magnesium/pharmacokinetics , Magnesium/pharmacology , Powders
6.
Drug Test Anal ; 5(5): 315-9, 2013 May.
Article in English | MEDLINE | ID: mdl-22012704

ABSTRACT

Genetic algorithm and partial least square (GA-PLS) and Levenberg-Marquardt artificial neural network (L-M ANN) techniques were used to investigate the correlation between retention time and descriptors for drug metabolites which obtained by two-dimensional liquid chromatography. The applied internal (leave-group-out cross validation (LGO-CV)) and external (test set) validation methods were used for the predictive power of four models. Both methods resulted in accurate prediction whereas more accurate results were obtained by L-M ANN model. The best model obtained from L-M ANN showed a good R(2) value (determination coefficient between observed and predicted values) for all compounds, which was superior to GA-PLS models.


Subject(s)
Chromatography, Liquid/methods , Neural Networks, Computer , Pharmaceutical Preparations/isolation & purification , Pharmaceutical Preparations/metabolism , Algorithms , Least-Squares Analysis , Models, Chemical
7.
Drug Test Anal ; 5(2): 89-95, 2013 Feb.
Article in English | MEDLINE | ID: mdl-21438162

ABSTRACT

Genetic algorithm (GA) and partial least squares (PLS) and kernel PLS (KPLS) techniques were used to investigate the correlation between immobilized liposome chromatography partitioning (log Ks) and descriptors for 65 drug compounds. The models were validated using leave-group-out cross validation LGO-CV. The results indicate that GA-KPLS can be used as an alternative modelling tool for quantitative structure-property relationship (QSPR) studies.


Subject(s)
Algorithms , Pharmaceutical Preparations/chemistry , Chromatography/methods , Least-Squares Analysis , Liposomes/chemistry , Models, Chemical , Neural Networks, Computer , Quantitative Structure-Activity Relationship
8.
Bone Marrow Transplant ; 47(8): 1082-6, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22080969

ABSTRACT

We retrospectively analyzed 44 patients undergoing first-line treatment for mantle cell lymphoma with R-HyperCVAD, with or without rituximab (R) maintenance or auto-SCT. The primary study end point was PFS; secondary end point was overall survival.Median follow up for all patients was 3.3 years. Median age was 54 years, and 95% (n=42) were stage III or IV at diagnosis. In all, 17 patients underwent consolidative auto-SCT and 12 patients received R maintenance. The overall response rate was 95%, with 91% achieving complete response (CR). Median PFS for all patients was 3.5 years. Median PFS was 2.3 years for patients treated with R-HyperCVAD alone vs 3.9 years (P=0.02) with R-HyperCVAD+ R maintenance and 4.5 years (P=0.01) with R-HyperCVAD+ auto-SCT. For patients who did not achieve CR at interim staging, PFS for R-HyperCVAD alone was 1.4 years vs not reached for R-HyperCVAD+ consolidation (either R maintenance or auto-SCT) (P=0.02). PFS for patients with CR at interim staging was 3.3 years vs not reached (P=0.04) after consolidation. Our data suggest potential improvement in PFS when R-HyperCVAD is consolidated with either R maintenance or auto-SCT. This benefit appears particularly significant in those patients who do not achieve CR at interim restaging.


Subject(s)
Antibodies, Monoclonal, Murine-Derived/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Lymphoma, Mantle-Cell/mortality , Lymphoma, Mantle-Cell/therapy , Stem Cell Transplantation , Disease-Free Survival , Female , Follow-Up Studies , Humans , Lymphoma, Mantle-Cell/pathology , Male , Middle Aged , Neoplasm Staging , Retrospective Studies , Rituximab , Survival Rate , Time Factors , Transplantation, Autologous
9.
Br J Cancer ; 86(8): 1333-5, 2002 Apr 22.
Article in English | MEDLINE | ID: mdl-11953894

ABSTRACT

STI571 is a selective tyrosine kinase inhibitor with proven therapeutic potential in malignancies expressing c-kit. A strong c-kit and stem cell factor expression was detected in the Hodgkin and Reed Sternberg cell line L1236, but not in 20 primary cases of classical Hodgkin's disease. Proliferation of L1236 cells was neither affected by addition of stem cell factor nor by neutralising anti-stem cell factor antibodies or STI571. Results suggest that patients with Hodgkin's disease may not benefit from therapy with STI571.


Subject(s)
Hodgkin Disease/pathology , Pyrimidines/pharmacology , Benzamides , Cell Division/drug effects , Drug Evaluation, Preclinical , Flow Cytometry , Hodgkin Disease/drug therapy , Humans , Imatinib Mesylate , Immunohistochemistry , In Situ Hybridization , Piperazines , Proto-Oncogene Proteins c-kit/genetics , Proto-Oncogene Proteins c-kit/metabolism , Pyrimidines/therapeutic use , Stem Cell Factor/metabolism , Tumor Cells, Cultured
10.
Blood ; 98(3): 762-70, 2001 Aug 01.
Article in English | MEDLINE | ID: mdl-11468177

ABSTRACT

Hodgkin disease (HD) represents a malignant lymphoma in which the putative malignant Hodgkin and Reed-Sternberg cells are rare and surrounded by abundant reactive nonmalignant cells. It has been suggested that cytokines such as interleukin-6 (IL-6) are involved in the pathogenesis of the disease. The expression of the IL-6 receptor (IL-6R) complex and its link to the activation of signal transducers and activators of transcription (STAT) molecules in HD cell lines was investigated. Gel retardation and Western blot analyses revealed a high level of constitutively activated STAT3 in 5 of 7 HD cell lines, which could not be detected in Burkitt lymphoma cell lines. Different levels of IL-6R protein were measured in various HD cell lines: L428 and Dev cells were characterized by very low levels of gp80 and gp130, on KMH2 cells only gp130 but no gp80 was detected, whereas L540, L591, HDLM2, and L1236 were positive for both gp80 and gp130, suggesting a possible autocrine stimulation of STAT3. However, a further increase in STAT3 activation on IL-6 or IL-6/soluble IL-6R stimulation was not observed. Neutralizing monoclonal antibodies against IL-6, gp80, gp130, or both receptor subunits did not affect the proliferation or the constitutive activation of STAT molecules in HD cell lines. However, the tyrosine kinase inhibitor AG490 blocked the constitutive activation of STAT3 and inhibited spontaneous growth of HD tumor cells. The evidence suggests abnormal STAT signaling and growth regulation in Hodgkin cell lines. (Blood. 2001;98:762-770)


Subject(s)
DNA-Binding Proteins/metabolism , Hodgkin Disease/pathology , Trans-Activators/metabolism , Antibodies, Monoclonal/pharmacology , Antigens, CD/immunology , Antigens, CD/metabolism , Antigens, CD/pharmacology , Cell Division/drug effects , Cytokine Receptor gp130 , DNA-Binding Proteins/drug effects , Enzyme Inhibitors/pharmacology , Hodgkin Disease/etiology , Hodgkin Disease/metabolism , Humans , Interleukin-6/immunology , Interleukin-6/physiology , Leukemia/metabolism , Lymphoma/metabolism , Membrane Glycoproteins/immunology , Membrane Glycoproteins/metabolism , Membrane Glycoproteins/pharmacology , Protein-Tyrosine Kinases/antagonists & inhibitors , Receptors, Interleukin-6/immunology , STAT1 Transcription Factor , STAT3 Transcription Factor , Trans-Activators/drug effects , Tumor Cells, Cultured
11.
Magn Reson Imaging ; 19(1): 41-6, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11295345

ABSTRACT

The objective of this study was to assess the value of MR imaging in the differentiation between a recurrent hepatocellular carcinoma (HCC) and a radiation-induced hepatic injury. Nine male patients with suspected recurrence after radiotherapy for HCC underwent T(2)-, T(1)-weighted imaging and Gd-DTPA enhanced dynamic studies. T(2) relaxation times, signal intensity ratios in T(1)-weighted images (WI) and the relative enhancement of the dynamic study were calculated. Recurrent tumors and the irradiated area showed similar image characteristics: hypointense in T(1)-WI and hyperintense in T(2)-WI. T(2) values and signal intensity ratios in the T(1)-WI were not significantly different. In the gadolinium-enhanced dynamic study, a recurrent HCC showed early enhancement, followed by a rapid washout. However, the irradiated liver parenchyma showed hyperintensity from an early phase, and contrast enhancement tended to be more prominent and prolonged at the end of the dynamic studies. The characteristic findings of the dynamic MR study enable us to distinguish between a recurrent HCC and a radiation-induced hepatic injury.


Subject(s)
Carcinoma, Hepatocellular/pathology , Liver Neoplasms/pathology , Liver/injuries , Magnetic Resonance Imaging , Radiation Injuries/pathology , Aged , Carcinoma, Hepatocellular/physiopathology , Diagnosis, Differential , Humans , Liver/pathology , Liver Neoplasms/physiopathology , Male , Recurrence
12.
Cancer Res ; 61(5): 2080-4, 2001 Mar 01.
Article in English | MEDLINE | ID: mdl-11280769

ABSTRACT

Hodgkin and Reed Sternberg (H-RS) cells represent the malignant cells in classical Hodgkin's disease. Although derived from germinal center B cells, they do not express surface immunoglobulin. This has been explained by the presence of crippling mutations within the immunoglobulin genes in numerous cases of Hodgkin's disease. As immunoglobulin gene expression in B cells requires an interaction between octamer sites and the transactivating factors Oct-2 and Bob-1, this study addresses the expression of the transcription factors Oct-2 and Bob-1 in H-RS cells. In Hodgkin's disease-derived cell lines, low levels of Oct-2 transcripts but no Oct-2 protein were detected. Transcripts of Bob-1, a B-cell-specific co-factor of Oct-2, could not be observed in these cell lines. Absence of Oct-2 and Bob-1 protein expression in primary H-RS cells was demonstrated by performing immunohistochemistry in 20 cases of classical Hodgkin's disease. H-RS cells stained negative for both proteins in all of the cases analyzed. In conclusion, absence of functional Oct-2 and Bob-1 cells represents a novel mechanism for immunoglobulin gene deregulation in H-RS cells. Lack of Oct-2 and Bob-1 points to a defect in transcription machinery in H-RS cells and is associated with lack of immunoglobulin gene expression in these cells.


Subject(s)
DNA-Binding Proteins/deficiency , Hodgkin Disease/metabolism , Reed-Sternberg Cells/metabolism , Trans-Activators/deficiency , Transcription Factors/deficiency , 3T3 Cells , Adolescent , Adult , Aged , Animals , DNA-Binding Proteins/biosynthesis , DNA-Binding Proteins/genetics , Genes, Immunoglobulin/genetics , Humans , Mice , Middle Aged , Octamer Transcription Factor-2 , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Trans-Activators/biosynthesis , Trans-Activators/genetics , Transcription Factors/biosynthesis , Transcription Factors/genetics , Transcription, Genetic , Tumor Cells, Cultured
13.
Magn Reson Imaging ; 18(6): 707-14, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10930780

ABSTRACT

The objective of this study was to describe magnetic resonance (MR) findings with a 1.5T imager for hepatic parenchymal changes after proton beam radiotherapy. Thirty-two patients who received proton radiotherapy with doses of 50-87 Gy underwent MR imaging 1-75 months (mean 22 months) after the start of irradiation. Axial T(2), T(1)-weighted imaging, and a dynamic study after a gadolinium injection were performed. The irradiated areas showed hypointense in T(1)-weighted images, hyperintense in T(2)-weighted images, and intense and prolonged enhancement on the dynamic study (maximum relative enhancement 441.8%+/-263.3 vs. surrounding liver 145.6%+/-67.7, p<0.0001). T(2) values of the irradiated areas were 50.6 to 65.8 msec greater than in the surrounding liver (p<0.005). The values increased with time, being significantly greater 13 months or longer after the beginning of the therapy than after a period of less than 3 months (p<0.05). Pathologic examinations (n = 3) indicated that the irradiated areas were composed of collapsed lobules with hepatic small vein occlusions, and rich extracellular matrices which retained extracellular fluid. MR imaging can demonstrate hepatic parenchymal changes after proton beam radiotherapy, and show the changes are irreversible.


Subject(s)
Liver Diseases/radiotherapy , Liver/pathology , Magnetic Resonance Imaging/methods , Adult , Aged , Female , Humans , Liver/radiation effects , Liver Diseases/diagnosis , Liver Diseases/pathology , Male , Middle Aged , Protons
14.
J Comput Assist Tomogr ; 24(4): 648-51, 2000.
Article in English | MEDLINE | ID: mdl-10966203

ABSTRACT

Early radiation-induced liver injury during radiotherapy detected by a particulate reticuloendothelial MR contrast agent (superparamagnetic iron oxide; SPIO) is described in a patient with cholangiocarcinoma. The irradiated hepatic parenchyma appeared as a heterogeneous, less decreased signal intensity area than the nonirradiated area on MR images after SPIO administration. Resultant differences in signal intensity were better visualized on SPIO-enhanced T1-weighted images than SPIO-enhanced T2-weighted images, although SPIO-enhanced T2*-weighted fast field echo imaging was the most sensitive.


Subject(s)
Liver/radiation effects , Magnetic Resonance Imaging/methods , Contrast Media/metabolism , Dextrans , Female , Ferrosoferric Oxide , Humans , Iron/metabolism , Liver/anatomy & histology , Liver/injuries , Magnetite Nanoparticles , Middle Aged , Oxides/metabolism
15.
J Comput Assist Tomogr ; 23(5): 655-63, 1999.
Article in English | MEDLINE | ID: mdl-10524841

ABSTRACT

PURPOSE: The purpose of this study was to investigate the long-term imaging appearances of hepatic injury following proton beam irradiation. The time-attenuation curves, time of appearance and recovery, and 3D size reduction pattern are described in patients of different ages and genders with different irradiation doses, irradiated portals, and Child groups. METHOD: Forty-six patients with hepatocellular carcinoma underwent 50 to 84 Gy proton beam irradiation in periods of 14-52 days. CT including noncontrast and dynamic study was performed every 3 months starting 3 weeks after the end of irradiation. The 3D volume measurement of areas of radiation-induced hepatic injury was performed through incremental dynamic CT images in every follow-up study. CT follow-up study of the patients was done for 12-76 months. RESULTS: Radiation-induced hepatic injury was observed as low attenuation areas on noncontrast CT and enhanced areas on dynamic study in the regions corresponding to the irradiation portals. Of our cases, 67.5% showed the appearance of radiation hepatitis in 3-4 weeks and 95.3% in 3-4 months after the end of irradiation. In both periods, there was a significant delay in the female patients. The time-attenuation curve showed an early and prolonged enhancement of the irradiated regions. The volume reduction pattern of the injured areas was found to be longstanding, exponential, and directed from periphery to the center. CONCLUSION: Early appearance of radiation-induced hepatic injury was found only to be gender dependent, with a tendency to occur with higher irradiated doses; no other parameters affected this phenomenon in our cases. Disappearance of the injured areas, if present, takes a long time (at least 42 months).


Subject(s)
Liver/diagnostic imaging , Liver/radiation effects , Protons/adverse effects , Radiation Injuries/diagnostic imaging , Tomography, X-Ray Computed , Adult , Aged , Carcinoma, Hepatocellular/complications , Carcinoma, Hepatocellular/diagnostic imaging , Carcinoma, Hepatocellular/radiotherapy , Chi-Square Distribution , Female , Follow-Up Studies , Humans , Liver Neoplasms/complications , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/radiotherapy , Male , Middle Aged , Proton Therapy , Radiation Injuries/etiology , Radiotherapy Dosage , Remission, Spontaneous , Sex Characteristics , Time Factors , Tomography, X-Ray Computed/instrumentation , Tomography, X-Ray Computed/methods , Tomography, X-Ray Computed/statistics & numerical data
16.
Clin Radiol ; 54(4): 253-6, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10210346

ABSTRACT

AIM: The aim of this study was to describe persistence of hypervascularity in proton treated hepatocellular carcinoma at serial follow-up computed tomography (CT). METHODS: Four patients with unresectable solitary hypervascular hepatocellular carcinoma underwent 55-82 Gy proton-beam irradiation for a period of 15-47 days. Follow-up CT including plain, enhanced and dynamic imaging was performed for a period of 9-36 months. RESULTS: Good preservation of arterial blood supply while gradual decrease in tumour size was clearly depicted by dynamic CT. CONCLUSION: We believe that preservation of hypervascularity as judged by enhancement at CT and magnetic resonance imaging, does not necessarily mean that radiotherapy in hypervascular malignant tumours has been unsuccessful.


Subject(s)
Carcinoma, Hepatocellular/blood supply , Liver Neoplasms/blood supply , Neovascularization, Pathologic/diagnostic imaging , Proton Therapy , Aged , Carcinoma, Hepatocellular/radiotherapy , Humans , Liver Neoplasms/radiotherapy , Male , Middle Aged , Tomography, X-Ray Computed
17.
Abdom Imaging ; 23(5): 520-6, 1998.
Article in English | MEDLINE | ID: mdl-9841067

ABSTRACT

Angiomyolipoma is a benign mesenchymal tumor that has been reported frequently in the kidney but rarely in the liver. In the present study, we present four cases of hepatic angiomyolipoma with different radiologic appearances, discuss differential diagnosis, and review previously reported cases. One of our cases was followed for 8 years. Computed tomography (plain, enhanced, and dynamic study), magnetic resonance imaging (T1-weighted spin echo, T2-weighted spin echo, and dynamic study), ultrasonography, and angiography were performed in all cases. Although different radiologic appearances were observed in the tumors, based on different proportions of fat, blood vessels, and muscle, three cases were diagnosed as angiomyolipoma. In one case, it was quite difficult to make radiologic diagnosis; hepatocellular carcinoma with fatty metamorphosis in part was most likely suspected, but histopathological examination revealed angiomyolipoma with few fat elements. In the present study, early and prolonged enhancement of the lesion with the special pattern of time density/intensity curve was significant for angiomyolipoma, and we suggest that preoperative radiologic diagnosis of the lesion is possible in most of the cases. However, it can be quite difficult to distinguish angiomyolipoma from some hepatocellular carcinomas with fatty metamorphosis.


Subject(s)
Angiomyolipoma/diagnosis , Liver Neoplasms/diagnosis , Magnetic Resonance Imaging , Tomography, X-Ray Computed , Adipose Tissue/diagnostic imaging , Adipose Tissue/pathology , Adult , Aged , Angiography , Angiomyolipoma/blood supply , Angiomyolipoma/diagnostic imaging , Blood Vessels/pathology , Carcinoma, Hepatocellular/diagnosis , Diagnosis, Differential , Female , Follow-Up Studies , Humans , Image Enhancement , Liver Neoplasms/blood supply , Liver Neoplasms/diagnostic imaging , Male , Middle Aged , Muscle, Skeletal/diagnostic imaging , Muscle, Skeletal/pathology , Radiographic Image Enhancement , Ultrasonography
18.
Radiat Med ; 15(4): 255-7, 1997.
Article in English | MEDLINE | ID: mdl-9311045

ABSTRACT

We report a 71-year-old male patient with multiple hepatic peribiliary cysts. The six-year follow-up through computed tomography (CT) imaging revealed increases in the size (from less than 10 mm to more than 38 mm) and number of the cysts.


Subject(s)
Bile Ducts, Intrahepatic/diagnostic imaging , Cysts/diagnostic imaging , Liver Diseases/diagnostic imaging , Tomography, X-Ray Computed , Aged , Follow-Up Studies , Humans , Male
19.
Radiology ; 202(2): 379-82, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9015061

ABSTRACT

PURPOSE: To determine the imaging characteristics of fulminant hepatic failure at serial computed tomography (CT) and to assess if any CT findings have prognostic value. MATERIALS AND METHODS: In 40 patients, 207 CT scans were analyzed retrospectively. Thirty-four patients had fulminant hepatic failure (acute in seven and subacute in 27), and six had late-onset hepatic failure. Twenty-one patients died of hepatic failure. CT was performed soon after the onset of coma and repeated weekly. Liver volume was measured by tracing the hepatic contour and summing the areas to estimate whole-liver volume. RESULTS: Liver volumes in survivors (n = 19) and nonsurvivors (n = 21), respectively, were 1,090 cm3 +/- 300 and 830 cm3 +/- 240 at initial CT and 1,130 cm3 +/- 310 and 700 cm3 +/- 280 at last CT (P = .0001). III-defined hypoattenuating areas were noted in 20 patients and were distributed in a solitary (n = 13), multiple (n = 6), or diffuse (n = 1) pattern. At follow-up CT, the area of hypoattenuation increased in six patients (five nonsurvivors) and disappeared or markedly decreased in four survivors. An increase in or late occurrence of ascites was noted in 15 patients (14 nonsurvivors, P = .0001). CONCLUSION: Liver volumes at the initial and last CT examinations and an increase in or late occurrence of ascites are useful prognostic findings.


Subject(s)
Hepatic Encephalopathy/diagnostic imaging , Liver/diagnostic imaging , Tomography, X-Ray Computed , Adolescent , Adult , Aged , Ascites/complications , Ascites/diagnostic imaging , Female , Hepatic Encephalopathy/complications , Humans , Male , Middle Aged , Prognosis , Retrospective Studies , Splenomegaly/complications , Splenomegaly/diagnostic imaging
20.
Radiat Med ; 15(6): 381-4, 1997.
Article in English | MEDLINE | ID: mdl-9495788

ABSTRACT

OBJECTIVE: The purpose of this study was to describe central dot sign (tiny dots with strong contrast enhancement of the portal vein within dilated hepatic bile ducts on computed tomography) in entities other than Caroli disease, especially in peribiliary cysts with or without autosomal-dominant polycystic kidney disease. MATERIALS AND METHODS: Computed tomography in 74 cases of peribiliary cysts and 134 cases of other liver diseases and states possibly showing central dot sign were retrospectively reviewed to examine the central dot sign. RESULTS: In three cases of peribiliary cysts, some part of the liver showed strongly enhanced portal radicles surrounded completely or partially by low-attenuation, enlarged peribiliary cysts, presenting "central dot sign" on contrast-enhanced computed tomography. CONCLUSION: We suggest that in addition to Caroli disease, some other entities and diseases of the liver may demonstrate central dot sign and this sign should not be considered a specific finding of Caroli disease.


Subject(s)
Bile Ducts, Intrahepatic/diagnostic imaging , Caroli Disease/diagnostic imaging , Liver Diseases/diagnostic imaging , Portal Vein/diagnostic imaging , Adult , Aged , Female , Humans , Male , Middle Aged , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL